1. Home
  2. OLMA vs VEL Comparison

OLMA vs VEL Comparison

Compare OLMA & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • VEL
  • Stock Information
  • Founded
  • OLMA 2006
  • VEL 2004
  • Country
  • OLMA United States
  • VEL United States
  • Employees
  • OLMA N/A
  • VEL N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • VEL Finance: Consumer Services
  • Sector
  • OLMA Health Care
  • VEL Finance
  • Exchange
  • OLMA Nasdaq
  • VEL Nasdaq
  • Market Cap
  • OLMA 725.5M
  • VEL 602.1M
  • IPO Year
  • OLMA 2020
  • VEL 2020
  • Fundamental
  • Price
  • OLMA $8.72
  • VEL $18.62
  • Analyst Decision
  • OLMA Strong Buy
  • VEL Strong Buy
  • Analyst Count
  • OLMA 6
  • VEL 3
  • Target Price
  • OLMA $23.00
  • VEL $21.67
  • AVG Volume (30 Days)
  • OLMA 1.5M
  • VEL 69.8K
  • Earning Date
  • OLMA 11-07-2025
  • VEL 11-06-2025
  • Dividend Yield
  • OLMA N/A
  • VEL N/A
  • EPS Growth
  • OLMA N/A
  • VEL 26.95
  • EPS
  • OLMA N/A
  • VEL 2.22
  • Revenue
  • OLMA N/A
  • VEL $195,592,000.00
  • Revenue This Year
  • OLMA N/A
  • VEL $3.99
  • Revenue Next Year
  • OLMA N/A
  • VEL $29.69
  • P/E Ratio
  • OLMA N/A
  • VEL $8.43
  • Revenue Growth
  • OLMA N/A
  • VEL 44.29
  • 52 Week Low
  • OLMA $2.86
  • VEL $16.12
  • 52 Week High
  • OLMA $13.51
  • VEL $20.98
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 47.84
  • VEL 58.25
  • Support Level
  • OLMA $7.80
  • VEL $17.74
  • Resistance Level
  • OLMA $8.48
  • VEL $18.91
  • Average True Range (ATR)
  • OLMA 0.76
  • VEL 0.33
  • MACD
  • OLMA -0.31
  • VEL 0.08
  • Stochastic Oscillator
  • OLMA 44.15
  • VEL 75.21

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VEL Velocity Financial Inc.

Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.

Share on Social Networks: